CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Us-china Biomedical Technology, Inc.  (CLDS)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Us-china Biomedical Technology Inc's

Competitiveness


 

CLDS Sales vs. its Competitors Q3 2018



Comparing the results to its competitors, Us-china Biomedical Technology Inc reported Total Revenue decrease in the 3 quarter 2018 year on year by 0 %, despite revenue increase by most of its competitors of 0 %, recorded in the same quarter.

List of CLDS Competitors





Revenue Growth Comparisons

Net Income Comparison


Us-china Biomedical Technology, Inc. recorded net loss , as well as most of its competitors.

<<  More on CLDS Income Comparisons


Us-china Biomedical Technology Inc's Comment on Competitors and Industry Peers


Our potential competitors include Chinese based patient referral companies and agencies who provide international healthcare referral services similar to ours, such as Hope Noah Company in Beijing, Saint Lucia Consulting in Beijing, Shanghai Medical Tourism Products and Promotion Platform, and Ryavo Healthcare in Shanghai. Our potential competitors have substantially greater financial, technical, and human resources than we do, as well as established market share and the commercialization of their services. Our competitors’ services may be more effective, or more effectively marketed and sold, than any services we may commercialize and may render our services obsolete or non-competitive before we can recover the expenses of their development and commercialization. We anticipate that we will continue to face intense and increasing competition as new service providers enter the market and if we cannot maintain solid relationships with top tier physicians and hospitals. However, we believe that if we are able to further develop our business plan, establish solid relationships, and provide our own medical technology which has been developed by our majority shareholder, we may have key potential advantages over competitive services that could enable us to capture meaningful market share from our competitors.

<<  See the full list of CLDS competitors



You need to upgrade your Flash Player


CLDS's vs. Competition, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME TICKER MARKET CAP REVENUES INCOME EMPLOYEES
Us-china Biomedical Technology, Inc. CLDS 7 0 -1 2
SUBTOTAL 7 0 -1 2
     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CRWE's Profile

Stock Price

CRWE's Financials

Business Description

Fundamentals

Charts & Quotes

CRWE's News

Suppliers

CRWE's Competitors

Customers & Markets

Economic Indicators

CRWE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071